Receptor binding in dopa-responsive dystonia

Annals of Neurology

Volumn 44, Issue 5, 1998, Pages 758-762

  Künig, Gabriella ^a,e   Leenders, Klaus L ^a   Antonini, Angelo ^d   Vontobel, Peter ^a   Weindl, Adolf ^b   Meinck, Hans M ^c  

^a PAUL SCHERRER INSTITUTE   (Switzerland)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^d PARKINSON INSTITUTE   (Italy)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DOPA; DOPAMINE; DOPAMINE 2 RECEPTOR; LEVODOPA; RACLOPRIDE; CARBON; DIAGNOSTIC AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; SALICYLAMIDE DERIVATIVE;

ADULT; AGED; ARTICLE; CAUDATE NUCLEUS; CLINICAL ARTICLE; DATA ANALYSIS; DOPAMINE METABOLISM; DOPAMINERGIC NERVE CELL; DYSTONIA; FEMALE; HUMAN; MALE; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN; RECEPTOR BINDING; RECEPTOR DENSITY; RECEPTOR UPREGULATION; ADOLESCENT; AGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MIDDLE AGED; ONSET AGE; REFERENCE VALUE; SCINTISCANNING;

ADOLESCENT; ADULT; AGE OF ONSET; AGING; CARBON RADIOISOTOPES; CAUDATE NUCLEUS; DIHYDROXYPHENYLALANINE; DOPAMINE; DOPAMINE ANTAGONISTS; DYSTONIA; FEMALE; HUMANS; MALE; MIDDLE AGED; PUTAMEN; RACLOPRIDE; RECEPTORS, DOPAMINE D2; REFERENCE VALUES; SALICYLAMIDES; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0031597417     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410440509     Document Type: Article

References (29)

1. Segawa M, Hosaka A, Miyagawa F, et al. Hereditary progressive dystonia with marked diurnal fluctuations. Adv Neurol 1976; 14:215-233
2. Nygaard TG, Trugman JM, de Yebenes JG, Fahn S. Dopa-responsive dystonia: the spectrum of clinical manifestations in a large North American family. Neurology 1990;40:66-69
3. Calne DB. Dopa-responsive dystonia. Ann Neurol 1994;35: 381-382
4. Takahashi H, Snow BJ, Nygaard TG, Calne DB. Clinical heterogeneity of dopa-responsive dystonia: PET observations. Adv Neurol 1993;60:587-590
5. Ichinose H, Ohye T, Takahashi E, et al. Hereditary progressive dystonia with marked diurnal fluctuations caused by mutation in the GTP cyclohydrolase I gene. Nat Genet 1994;8:236-242
6. Knappskog PM, Flatmark T, Mallet J, et al. Recessively inherited levodopa-responsive dystonia caused by a point mutation (Q381K) in the tyrosine hydroxylase gene. Hum Mol Genet 1995;4:1209-1212
7. Furukawa Y, Shimadzu M, Rajput AH, et al. GTP-cyclohydrolase I gene mutations in hereditary progressive and dopa-responsive dystonia. Ann Neurol 1996;39:609-617
8. Nygaard TG, Takahashi H, Heiman GA, et al. Long-term treatment response and fluorodopa positron emission tomographic scanning of parkinsonism in a family with dopa-responsive dystonia. Ann Neurol 1992;32:603-608
9. Nygaard TG, Marsden CD, Fahn S. Dopa-responsive dystonia: long term treatment response and prognosis. Neurology 1991; 41:174-181
10. 18F] Dopa positron emission tomography. Ann Neurol 1991;30:24-30
11. 18F]-dopa uptake in adult-onset dystonia-parkinsonism, Parkinson's disease, and dopa-responsive dystonia. Neurology 1993;43:1563-1568
12. Snow BJ, Nygaard TG, Takahashi H, Calne DB. Positron emission tomographic studies of dopa-responsive dystonia and early-onset idiopathic parkinsonism. Ann Neurol 1993;34:733-738
13. 11C]-raclopride. J Neurol Sci 1995;132:156-161
14. Antonini A, Vontobel P, Psylla M, et al. Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease. Arch Neurol 1995;52: 1183-1190
15. Lammertsma AA, Hume SP. Simplified reference tissue model for PET receptor studies. Neuroimage 1996;4:153-158
16. 2 receptors in dopa-responsive dystonia and Parkinson's disease. In: Segawa M, Nomura Y, eds. Age related dopamine dependent disorders, vol 14. Monograph in Neural Sciences. Basel: Karger, 1995:95-100
17. 11C]-raclopride. Mov Disord 1997;12:33-38
18. 2 receptors. Neurology 1994;44: 1325-1329
19. Calne DB, Zigmond MJ. Compensatory mechanisms in degenerative neurologic diseases. Arch Neurol 1991;48:361-363
20. Rajput AH, Gibb WRG, Zhong XH, et al. Dopa-responsive dystonia: pathological and biochemical observations in a case. Ann Neurol 1994;35:396-402
21. Lidsky TI, Schneider JS, Yablonsky-Alter E, et al. Taurine prevents haloperidol-induced changes in striatal neurochemistry and behavior. Brain Res 1995;686:104-106
22. 2 receptor binding. Science 1996;273:1225-1227
23. 11C]-raclopride in the human brain. Synapse 1994;16:255-262
24. 2-dopamine receptors in the monkey brain. Synapse 1997;25:321-325
25. 11C]-raclopride binding in rat striatum, quantified using PET. Synapse 1995;21:45-53
26. 11C]raclopride displacement and PET. Neurology 1996;46:1430-1436
27. 11C]-raclopride. Arch Neurol 1993;50:474-480
28. Marsden CD, Obeso JA, Zarranz JJ, Lang AE. The anatomical basis of symptomatic hemidystonia. Brain 1985;108:463-483
29. Kostic VS, Stojanovic-Svetel M, Kacar A. Symptomatic dystonias associated with structural lesions: report af 16 cases. Can J Neurol Sci 1996;23:53-56